Equities

Plant Advanced Technologies PAT SA

Plant Advanced Technologies PAT SA

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (EUR)14.00
  • Today's Change-0.50 / -3.45%
  • Shares traded705.00
  • 1 Year change+3.70%
  • Beta0.7477
Data delayed at least 15 minutes, as of Jun 14 2024 16:35 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Plant Advanced Technologies PAT SA is a France-based life sciences company focusing on eco-friendly plant extracts production for pharmaceutical and cosmetic industries. It is also engaged in the research and development in the field of plant biotechnology. The Company patented its own production technologies, such as PAT Plant Milking, active natural compounds production system based on roots exudation of plants grown hydroponically or PAT Friday, a recombinant protein expression system using natural protein excretion system of genetically modified carnivorous to produce outside their leaf, in a sterile closed pitcher, the protein of interest in liquid. In addition PAT is involved in the development and sale of know-how, licenses and sub-licenses for its technologies.

  • Revenue in EUR (TTM)1.68m
  • Net income in EUR79.16k
  • Incorporated2005
  • Employees56.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Acticor Biotech SA0.00-18.65m10.75m24.00--22.87-----1.68-1.680.000.02980.00----0.00-145.59---297.22-------------9.320.9504-------25.94------
NicOx SA3.57m-17.36m13.35m11.00--0.2909--3.74-0.3721-0.37210.07530.91280.0394--1.83324,909.10-19.13-19.22-21.35-20.78-----485.70-370.14----0.3172---54.787.2536.57---13.35--
Ikonisys SA538.56k-2.40m15.19m11.00--0.8235--28.21-0.2499-0.24990.0561.750.02461.146.2048,960.00-10.94---12.55--2.72---444.76--0.0818-36.790.1007--68.94---328.57------
Plant Advanced Technologies PAT SA1.68m79.16k15.53m56.00193.241.8126.789.230.07250.07251.547.730.1118-0.41231.60--0.5262-3.530.6534-4.39128.03134.214.71-33.160.4183-15.320.3402--8.568.05119.67-38.00----
Valerio Therapeutics SA1.80m-20.34m16.05m19.00--1.08--8.92-0.1566-0.15660.01330.09610.0459--1.0794,736.84-51.92-34.19-67.72-40.5970.3984.11-1,130.22-586.99---171.660.3776--24.74-21.73-4.00--32.39--
Nfl Biosciences SAS0.00-3.48m19.99m3.00--5.03-----0.5396-0.53960.000.40970.00----0.00-80.79---125.59--------------0.0228-------149.78------
Oncodesign Precision Medicine Opm SA1.07m-8.09m20.01m22.00--4.96--18.66-0.4863-0.48630.06450.22190.0613--1.3948,735.00-46.23---63.87--130.48---754.61------0.7052---86.57---3,399.73------
SMAIO SA7.62m1.06m20.13m37.0018.901.868.462.640.20380.20381.462.070.56240.187117.23206,027.607.81-7.8710.24-19.7696.9596.0413.89-22.482.5411.070.1991--212.18114.99-62.80------
Valbiotis SA4.73m-7.37m20.38m52.00--1.04--4.30-0.5904-0.59040.37981.240.15643.3617.8391,019.23-24.35-32.92-33.77-46.3648.7653.15-155.67-418.873.38-38.190.2598--502.93126.7340.16---21.71--
Data as of Jun 14 2024. Currency figures normalised to Plant Advanced Technologies PAT SA's reporting currency: Euro EUR

Institutional shareholders

1.83%Per cent of shares held by top holders
HolderShares% Held
Gay-Lussac Gestion SAas of 31 Dec 202220.00k1.83%
Data from 30 Jun 2023 - 30 Jun 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.